Contract research organisation (CRO) Quanticate has announced a partnership with fellow UK company Atlantic-Global to produce a customised, fully web-enabled Project Portfolio Management System.
Based in Cleckheaton, West Yorkshire, Atlantic-Global develops and supplies pharmaceutical project management and other business support software. Bringing together the company’s Corporate Vision software with Quanticate’s clinical trial and project management capabilities will enable the latter to manage its complex global biometrics programme from inception to completion in a single environment, Quanticate said.
“Working with our customers, we are able to predict, monitor and control project performance, and proactively respond to the ever-present issues that might otherwise affect project performance,” commented Mark Campbell, head of project management for Quanticate.
The company has already been deploying multiple modules of the customised system, offering strategic and project resource planning, risk and issue management and project financial management as well as a report suite to support all project activities.
Ensuring the visibility of each level of project management is critical, particularly in a tough economic environment, Quanticate pointed out. The company plans to open up the Project Portfolio Management to its customers by early autumn 2009.
Billing itself as “the largest global biometrics company with full-service clinical trial capabilities”, Quanticate was formed in December 2007 through the combination of two existing CROs, Statwood and Oxford Pharmaceutical Sciences. The company has headquarters in London, UK and Cambridge, US.
